STOCKMARKETLOOP MARKET SIGNAL$MDGLMadrigal PharmaceuticalsOpen ticker analysis →
Madrigal Pharmaceuticals received a fresh analyst action dated 2026-09-23.
What changed for $MDGL?
Fresh rating and price-target changes can alter expectations and near-term positioning.
| New rating | BUY |
|---|---|
| Prior rating | BUY |
| New target | $725.00 |
| Prior target | $505.00 |
| Firm | Citi |
LOADING $MDGL LIVE MARKET DATA
What does this $MDGL signal not prove?
An analyst opinion is not a guarantee, and target prices can be revised without warning.
